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Insulin resistance, an impaired biological response to circulating
insulin, is a disorder common to most of the obesity-related diseases
and, as such, represents an important target of medical research. The
precise etiology of impaired insulin action in obese people is still
unknown; however, an increasing body of evidence indicates that it
may be associated with alterations in intracellular lipid metabolism.
Insulin-resistant humans and animals accumulate significant amounts
of lipids not only in the adipose tissue, but also in liver, muscle and
other peripheral tissues. Storage of even a modest caloric surplus in
lean, insulin sensitive tissues leads to insulin resistance. Altered lipid
metabolism as seen in the insulin-resistant states largely depends on
the aberrant expression of genes encoding key metabolic enzymes.
Consequently, several enzymes regulating lipidmetabolism have been
recently proposed as therapeutic targets. One of these enzymes,
stearoyl-CoA desaturase (SCD), appears to be of special significance,
because SCD1 is the major gene target of leptin, which is the central
mediator regulating energy homeostasis and a known insulin-
sensitizer. Increasing evidence suggests that SCD, the rate limiting
enzyme of monounsaturated fatty acid biosynthesis, is an important
factor in the pathogenesis of lipid-induced insulin resistance. Mice
with a targeted disruption of the SCD1 gene have improved glucose
tolerance compared to wild-type mice, despite lower fasting plasma
insulin levels. Increased SCDactivity has been found in insulin resistant
humans and animals, whereas SCD1 deficiency attenuates both diet-
and genetically-induced impairment of insulin action. In skeletal
muscle and in brown adipose tissue, basal tyrosine phosphorylation of
the IRS1 and IRS2, the association of both IRS1 and IRS2 with the ap85
subunit of phosphatidyl-inositol 3-kinase, the phosphorylation of Akt
and membrane GLUT4 translocation are all elevated in SCD1−/−mice
comparedwithwild-typemice. Our recent study showed that deletion
of SCD1 gene protects muscle against lipid-induced insulin resistance.
While the precise mechanism of SCD action on insulin signaling
remains to be clarified, current findings on SCD point to a very
promising novel strategy for the treatment of insulin resistance.
doi:10.1016/j.bbabio.2010.04.236
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The dual localization of fatty acid synthesis (FAS) in eukaryotic cells
raises the question of why have eukaryotes maintained the FAS in the
mitochondria in additions to the “classic” cytoplasmic FAS. The
mitochondrial FAS is composed of a discrete set of monofunctional
enzymes resembling the bacterial FAS system in contrast to the
eukaryotic cytosolic multifunctional complex. Yeast cells deficient in
mitochondrial FAS have rudimentary mitochondria and a respiratory
deficient phenotype, exhibit loss of spectrally detectable cytochromes,
and are defective in mitochondrial RNA processing [3,4]. One task of
the mitochondrial FAS is to generate octanoyl-ACP which is used for
lipoic acid synthesis. This is apparently also a conserved and essential
process in mammals. Lipoic acid is required for the function of several
multienzyme complexes involved in the oxidative decarboxylation of
α-keto-acids and glycine. The mechanistic details of lipoic acid
metabolism are unclear in eukaryotes, despite two well-defined
pathways for synthesis and covalent attachment of lipoic acid in
prokaryotes. Recently we demonstrated the involvement of four genes
in the synthesis and attachment of lipoic acid in Saccharomyces
cerevisiae. LIP2 and LIP5 are required for lipoylation of all three mito-
chondrial target proteins: Lat1 and Kgd2, the respective E2 subunits of
pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, and
Gcv3, the H protein of the glycine cleavage enzyme. LIP3, which
encodes a lipoate-protein ligase homolog, is necessary for lipoylation
of Lat1 and Kgd2, and the enzymatic activity of Lip3 is essential for this
function. GCV3, encoding the H protein target of lipoylation, is itself
absolutely required for lipoylation of Lat1 andKgd2 [5]. Recently pieces
of evidence have been emerging which link the mtFAS pathway to
disease in mammals. Our recent report on the development of
cardiomyopathy in mice overexpressing Etr1 established a possible
connection between mtFAS and heart disease [1]. The expression of
17βHSD8, encoding a subunit in KAR1 [2], has been reported to be
repressed in kidney and liver of polycystic kidney disease mouse
models.
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